ANDRE FRANCI

(Fonte: Lattes)
Índice h a partir de 2011
5
Lattes
ResearcherID
Projetos de Pesquisa
Unidades Organizacionais
LIM/11 - Laboratório de Cirurgia Cardiovascular e Fisiopatologia da Circulação, Hospital das Clínicas, Faculdade de Medicina

Filtros

Limpar filtros

Configurações

Indexador: Scopus ×

Resultados de Busca

Agora exibindo 1 - 1 de 1
  • article 0 Citação(ões) na Scopus
    Effects of exercise on platelet reactivity after myocardial infarction: a randomized clinical trial
    (2023) DALCOQUIO, Talia Falcao; SANTOS, Mayara Alves dos; ALVES, Leandro Silva; ARANTES, Flavia Bittar Brito; FERREIRA-SANTOS, Larissa; RONDON, Maria Urbana Pinto Brandao; FURTADO, Remo Holanda M.; FERRARI, Aline Gehlen; RIZZO, Paulo Roberto Genestreti; SALSOSO, Rocio; FRANCI, Andre; BARACIOLI, Luciano Moreira; ALVES, Maria Janieire de Nazare Nunes; NEGRAO, Carlos Eduardo; NICOLAU, Jose Carlos
    Exercise training (ET) can lower platelet reactivity in patients with cardiovascular risk factors. However, the effects of ET on platelet reactivity in higher-risk patients is unknown. The aim of this study was to evaluate the effects of ET on platelet reactivity in patients with recent myocardial infarction (MI). Ninety patients were randomly assigned 1 month post-MI to the intervention (patients submitted to a supervised ET program) or control group. All patients were on dual antiplatelet therapy (DAPT). Platelet reactivity by VerifyNow-P2Y(12) (measured by P2Y(12) reaction units - PRU5) test was determined at baseline and at the end of 14 +/- 2 weeks of follow-up at rest (primary endpoint), and multiplate electrode aggregometry (MEA) adenosine diphosphate (ADP) and aspirin (ASPI) tests were performed immediately before and after the maximal cardiopulmonary exercise test (CPET) at the same time points (secondary endpoints). Sixty-five patients (mean age 58.9 +/- 10 years; 73.8% men; 60% ST elevation MI) completed follow-up (control group, n = 31; intervention group, n = 34). At the end of the follow-up, the mean platelet reactivity was 172.8 +/- 68.9 PRU5 and 166.9 +/- 65.1 PRU5 for the control and intervention groups, respectively (p = .72). Platelet reactivity was significantly increased after the CPET compared to rest at the beginning and at the end of the 14-week follow-up (among the intervention groups) by the MEA-ADP and MEA-ASPI tests (p < .01 for all analyses). In post-MI patients on DAPT, 14 weeks of supervised ET did not reduce platelet reactivity.